Variable Charge Y-Linked (VCY) proteins are a unique set of proteins encoded by genes present on the Y chromosome. Expressed predominantly in the testis, they have garnered interest for their potential involvement in spermatogenesis, though the full extent of their biological roles and interactions is not entirely elucidated. As researchers delve deeper into the intricate networks of cellular processes, understanding the modulation of such proteins becomes paramount. Enter VCY inhibitors: a class of chemical entities specifically designed or identified to dampen or suppress the expression or function of VCY proteins.
The world of VCY inhibitors is expansive. These chemical compounds act at various stages of the VCY protein lifecycle. Some might interfere at the genetic level, targeting the transcriptional machinery responsible for converting the VCY gene into mRNA. Others target the translational mechanisms, ensuring that the mRNA does not successfully translate into the functional VCY protein. Another subset may act post-translationally, altering the stability or function of the VCY proteins after they have been synthesized. Additionally, epigenetic modulators could also play a role; these inhibitors might alter the chromatin landscape around the VCY gene, making it less accessible to the cellular machinery and thereby reducing its expression. The diversity in the modes of action offers researchers a broad spectrum of tools to dissect the importance and function of VCY in cellular biology. As the scientific community advances in its understanding, the exploration of these inhibitors will be pivotal in revealing the nuances of Y-chromosome associated proteins and their contributions to cellular dynamics.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D may bind to DNA regions associated with the VCY gene, possibly obstructing its transcription. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
This compound could selectively hinder the translation of VCY mRNA, potentially reducing its protein production. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By modifying the methylation patterns of genes, 5-Azacytidine might affect the transcription of the VCY gene. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
By inhibiting histone deacetylase, Trichostatin A might influence chromatin structure around the VCY gene, potentially suppressing its expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
This compound could inhibit RNA polymerase II, leading to a decrease in VCY mRNA transcription. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin could affect DNA topoisomerase I function, possibly impacting replication and transcription of the VCY gene. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
By inhibiting glycolysis, 2-Deoxyglucose might reduce cellular energy essential for VCY synthesis. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB could obstruct RNA polymerase II, potentially leading to a decrease in VCY mRNA synthesis. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
By affecting ribonucleotide reductase, hydroxyurea could impact DNA synthesis and the transcription of the VCY gene. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin might bind to Hsp90, possibly leading to destabilization or degradation of proteins requiring Hsp90 for proper folding, including potentially VCY. | ||||||